Buprenorphine Sublingual C-iii Tablet
Product Images NDC 72189-582

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Buprenorphine Sublingual C-iii (NDC 72189-582). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Direct_rx, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72189-582-60 (72189 582 60)

Packaging label for Buprenorphine Sublingual C-III 8 mg tablets, containing 60 tablets per package. The label states it is a generic for Subutex, with each tablet containing 8.64 mg of buprenorphine HCL USP equivalent to 8 mg of buprenorphine base. The label includes lot number SAMPLE, expiration date 9/30/25, and distributor Direct Rx, packaged in Dawsonville, GA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.